… with aspirin and a P2Y 12 inhibitor has been shown to reduce the risk of major adverse
cardiovascular events (MACE) compared with aspirin alone … aspirin in favor of P2Y 12 inhibitor …

Background and purpose: We performed a systemic review and meta-analysis to elucidate
the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors (…

… 1 year after randomisation, when patients continued to be treated with ticagrelor alone or
aspirin alone. All analyses were performed according to the intention-to-treat principle. The two-…

… to compare P2Y12 inhibitor monotherapy versus aspirin … Monotherapy with P2Y12 inhibitors
(clopidogrel or ticagrelor) … 0.92, I2 = 0%) compared with aspirin monotherapy. There was no …

… benefit of ticagrelor in those who had received aspirin in the … with aspirin and ticagrelor
may be superior to aspirin alone, … attack treated with ticagreLor and aspirin for prEvention of …

… 12 inhibitor monotherapy vs aspirin in patients with CAD. … P2Y 12 inhibitors (clopidogrel,
prasugrel, or ticagrelor) vs aspirin … of P2Y 12 inhibitor monotherapy vs aspirin monotherapy after …

… Second, although we compared aspirin versus P 2 Y 12 inhibitor, the P 2 Y 12 inhibitor
evaluated varied (clopidogrel vs ticagrelor), and there were insufficient data to further evaluate …

… The aim of this study was to compare aspirin vs P2Y 12 inhibitor (P2Y 12 -I) monotherapy
after dual antiplatelet therapy (DAPT) discontinuation in patients undergoing percutaneous …

… mice were administered aspirin or coagulation inhibitors (C921… that (1) thrombin inhibitors
and aspirin have a demonstrable … in vivo by the inclusion of aspirin and/or a thrombin inhibitor. …

… aspirin (100 mg/day), placebo + aspirin alone (100 mg/day) or placebo + rivaroxaban alone
(… For the purposes of this analysis, only data from the rivaroxaban + aspirin and aspirin alone …